The DOI matches its Crossref record.
Studies of hematopoietic stem cells spared by 5-fluorouracil.
Open accessAbstract
Mouse marrow cells were exposed to 5-fluorouracil (FU) either in vivo or in vitro and the effects on the hematopoietic stem cell compartment were studied. The drug was highly toxic to bone marrow cells including the spleen colony-forming unit (CFU-S) population. The small population of stem cells surviving FU, however, caused a different pattern of spleen colony growth when injected into lethally irradiated mice. Whereas numbers of spleen colonies caused by normal marrow cells remained constant during an 8-14 d period after transplantation, spleen colonies derived from FU-treated marrow cells increased by as much as 100-fold during this time. This effect on stem cells was dose dependent both in vitro and in vivo. When FU was given in vivo, the day 14/day 8 ratio of colonies was greatest 1 d after injection and, over the next 7 d, returned to a near-normal value, that is, unity. A number of studies have shown that the stem cell compartment is heterogeneous with respect to self-replicative capacity and developmental potential. An age structure for the stem cell compartment has been proposed wherein cells with a short mitotic history are more likely to self-replicate than they are to differentiate; hence they are more primitive. 'Older' stem cells with a longer mitotic history are, according to the hypothesis, more likely to differentiate. 5-fluorouracil may be toxic to the older stem cells and selectively spare the more primitive subpopulation. Although the surviving cells may not themselves be able to form spleen colonies, they may give rise to an older cohort of cells more likely to differentiate and form spleen colonies. It is the requisite developmental maturation within the stem cell compartment that may be responsible for the delay in appearance of spleen colonies derived from FU-treated marrow. Our results support this explanation and identify the locus of at least part of this activity as the bone marrow. We found that the FU-treated marrow did not cause an increase in spleen colony numbers between 8 and 14 d in hosts with a long-standing marrow aplasia, due to the incorporation of 89Sr into bone. I propose that the delayed spleen colony appearance in normal hosts is the result of developmental maturation of the primitive stem cell compartment that survives FU and is responsible for spleen colonies arising around day 14. This maturation, at least initially, occurs in the marrow and leads to the replenishment of the more differentiated CFU-S subsets ablated by FU, which are normally responsible for spleen colonies appearing earlier after transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
The bone marrow microenvironment at single-cell resolution
Tikhonova, A. N., Dolgalev, I., Hu, H., Sivaraj, K. K., Hoxha, E., Cuesta-Domínguez, Á., Pinho, S., Akhmetzyanova, I., Gao, J., Witkowski, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1104-8 · Cited by 936
In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
Cheshier, S. H., Morrison, S. J., Liao, X., & Weissman, I. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3120 · Cited by 858
Developmental potential and dynamic behavior of hematopoietic stem cells
Lemischka, I. R., Raulet, D. H., & Mulligan, R. C. (1986) · Cell · doi:10.1016/0092-8674(86)90566-0 · Cited by 848
Zsebo, K. M., Wypych, J., McNiece, I. K., Lu, H. S., Smith, K. A., Karkare, S. B., Sachdev, R. K., Yuschenkoff, V. N., Birkett, N. C., Williams, L. R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90300-4 · Cited by 788
The Biology of Hematopoietic Stem Cells
Morrison, S. J., Uchida, N., & Weissman, I. L. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000343 · Cited by 778
Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D. J., Zhu, Z., Bohlen, P., Witte, L., et al. (2002) · Nature Medicine · doi:10.1038/nm740 · Cited by 633
Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells
Foudi, A., Hochedlinger, K., Van Buren, D., Schindler, J. W., Jaenisch, R., Carey, V., & Hock, H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1517 · Cited by 586
In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells
Okada, S., Nakauchi, H., Nagayoshi, K., Nishikawa, S., Miura, Y., & Suda, T. (1992) · Blood · doi:10.1182/blood.v80.12.3044.3044 · Cited by 523
Fleming, H. E., Janzen, V., Lo Celso, C., Guo, J., Leahy, K. M., Kronenberg, H. M., & Scadden, D. T. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.003 · Cited by 505
Aging of hematopoietic stem cells
de Haan, G., & Lazare, S. S. (2018) · Blood · doi:10.1182/blood-2017-06-746412 · Cited by 432
Beerman, I., Seita, J., Inlay, M. A., Weissman, I. L., & Rossi, D. J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.016 · Cited by 445
“To examine how old damaged HSCs would respond to induced cycling in vivo, we injected aged animals with 5-fluorouracil (5-FU), an agent that kills cycling cells (Van Zant, 1984) and drives the quiescent HSCs into cycle (Harrison and Lerner, 1991).”
BackgroundThe role of hypoxia in the maintenance of hematopoietic stem cells
Cipolleschi, M., Dello Sbarba, P., & Olivotto, M. (1993) · Blood · doi:10.1182/blood.v82.7.2031.2031 · Cited by 391
Molecular Signatures of Proliferation and Quiescence in Hematopoietic Stem Cells
Venezia, T. A., Merchant, A. A., Ramos, C. A., Whitehouse, N. L., Young, A. S., Shaw, C. A., & Goodell, M. A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020301 · Cited by 362
Moore, M. A., & Warren, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7134 · Cited by 357
GATA-2 Plays Two Functionally Distinct Roles during the Ontogeny of Hematopoietic Stem Cells
Ling, K.-W., Ottersbach, K., van Hamburg, J. P., Oziemlak, A., Tsai, F.-Y., Orkin, S. H., Ploemacher, R., Hendriks, R. W., & Dzierzak, E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031556 · Cited by 316
Resting and activated subsets of mouse multipotent hematopoietic stem cells.
Spangrude, G. J., & Johnson, G. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7433 · Cited by 313
Scott, L. M., Priestley, G. V., & Papayannopoulou, T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9349-9360.2003 · Cited by 301
Randall, T. D., & Weissman, I. L. (1997) · Blood · doi:10.1182/blood.v89.10.3596 · Cited by 290
Bodine, D. M., Karlsson, S., & Nienhuis, A. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8897 · Cited by 290
Hao, Q., Thiemann, F., Petersen, D., Smogorzewska, E., & Crooks, G. (1996) · Blood · doi:10.1182/blood.v88.9.3306.bloodjournal8893306 · Cited by 258
Hata, K., Horii, T., Miyazaki, M., Watanabe, N.-A., Okubo, M., Sonoda, J., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-11 · Cited by 149
de Haan, G., & van Zant, G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.6.707 · Cited by 87
Tian, C., Bagley, J., Forman, D., & Iacomini, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302695 · Cited by 30
Nakano, T., Waki, N., Asai, H., & Kitamura, Y. (1989) · Blood · doi:10.1182/blood.v73.5.1175.1175 · Cited by 14
Metadata
- Authors
- Van Zant, G.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1984-03-01
- Volume
- 159
- Issue
- 3
- Pages
- 679-690
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2149886995
- Cited by
- 203
- References
- 0
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.